Treatment of Post-Viral Anosmia
Olfactory training should be initiated immediately and continued for a minimum of 3-6 months as the primary evidence-based treatment for post-viral anosmia. 1
Primary Treatment Approach
Olfactory Training (First-Line Therapy)
- Start olfactory training immediately upon diagnosis and continue for at least 3-6 months, as recommended by the European Rhinologic Society 1
- Patients should be referred to validated resources for proper training technique (such as www.fifthsense.org.uk) 2
- This intervention has moderate strength of evidence and represents the cornerstone of management 1
Initial Assessment Requirements
- Perform objective psychophysical testing using validated instruments (UPSIT or Sniffin'Sticks) rather than relying on patient self-assessment, as patients typically cannot accurately gauge their impairment severity 1
- Conduct rigid nasal endoscopy to differentiate between conductive and sensorineural causes 1
- Document temporal relationship to viral infection, associated symptoms (nasal obstruction, rhinorrhea, flu-like illness), and predisposing factors 1
Recovery Timeline and Prognosis
Expected Natural History
- Recovery occurs in 44-73% of COVID-19 patients within the first month, though some develop persistent dysfunction 2, 1
- Complete resolution was seen in 13% and partial resolution in 14% of patients, with mean time to improvement of 7.2 days in early reports 2
- Recovery typically takes place within a few weeks, but longer timeframes are possible 2
- One case series showed recovery by day 17 in one patient, while others had persistent dysfunction requiring ongoing management 2
Adjunctive Treatment Considerations
Corticosteroid Therapy (Limited Evidence)
- The evidence for systemic corticosteroids combined with intranasal steroid/mucolytic/decongestant solution is very uncertain based on one small study of 18 participants 3
- This study showed 5/9 participants in the treatment group achieved normal olfactory function (CCCRC score ≥90) compared to 0/9 in the control group after 40 days, but the confidence interval was extremely wide (RR 11.00,95% CI 0.70 to 173.66) 3
- Given the very low-certainty evidence, corticosteroids should not be routinely recommended as first-line therapy 3
Treating Underlying Sinonasal Disease
- Address any sinonasal inflammatory disease with appropriate medical or surgical management before or concurrent with olfactory training 1
- This is particularly important if nasal endoscopy reveals obstructive pathology 1
Follow-Up Protocol
Structured Monitoring Schedule
- Re-evaluate patients at 1 month, 3 months, and 6 months after initiating treatment 1, 4
- Repeat objective psychophysical testing at each follow-up visit to document changes objectively 1
- Refer to an otolaryngologist or specialized smell/taste clinic if no improvement occurs after 3-6 months of olfactory training 1, 4
Supportive Management
Dietary and Quality of Life Interventions
- Refer patients to a registered dietitian for counseling on flavor enhancement, additional seasoning, and expanding dietary options 1, 4
- Address safety concerns related to inability to detect spoiled food or gas leaks 4
- Provide counseling about the impact on quality of life, as persistent olfactory dysfunction can have profound effects 3
Common Pitfalls to Avoid
Diagnostic Errors
- Do not rely on patient self-assessment of olfactory function severity, as objective testing reveals much higher rates of dysfunction (98.3% by UPSIT testing even when only 35% reported complaints) 5
- Do not order unnecessary neuroimaging (CT/MRI) when there is a clear temporal relationship to viral infection and no red flag symptoms (facial pain, serosanguinous discharge, visual changes) 2, 4
Treatment Misconceptions
- Do not prescribe systemic corticosteroids routinely, as the evidence is very uncertain and limited to one very small study 3
- Do not delay initiation of olfactory training while waiting for spontaneous recovery, as early intervention is recommended 1
- Recognize that most "taste loss" actually reflects loss of retronasal olfaction (flavor perception) rather than true taste dysfunction 5
COVID-19 Specific Considerations
- Perform COVID-19 testing in all patients with sudden-onset olfactory dysfunction, especially during pandemic periods, as anosmia may be the sole presenting symptom 1, 4
- Advise self-isolation as recommended by the World Health Organization for patients with anosmia during active infection periods 5
Alternative Approaches (Emerging Evidence)
Integrative Medicine
- One case study reported complete recovery within 4 months using Ayurveda (Shadbindu taila nasya) combined with Traditional Chinese Acupuncture at specific points (GV.20, LI.20, Ex.1, H.7, LI.11, GB.8, GB.21, GV.25) 6
- However, this represents very low-quality evidence from a single case report and cannot be recommended as standard practice 6